Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00274638 · ClinicalTrials.gov registry record · Phase 4
PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)
A Phase 4 study, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- Phase 4
- Development phase
- 805
- Enrollment target
NCT00274638: Completed Phase 4 study, sponsored by Boehringer Ingelheim.
NCT00274638 is a Phase 4 study that has completed, run by Boehringer Ingelheim. The registered enrollment target is 805 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (55% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00274638, a Phase 4 study, has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 805 participants
- Enrollment target
Study Summary
To demonstrate that Telmisartan combined with Hydrochlorothiazide (MICARDIS® HCT) is superior to Losartan with Hydrochlorothiazide (Hyzaar®) in lowering blood pressure in mild-moderate hypertensives.
Interventions
- DRUG Telmisartan & Hydrochlorothiazide
- DRUG Losartan & Hydrochlorothiazide
- PROCEDURE ABPM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 805 participants |
| Start Date | 2002-07 |
| Phase | Phase 4 |
What the finished NCT00274638 record still lists
NCT00274638 is an interventional study that assigns participants to a tested intervention. The registered 805 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (55% higher).
The record links to 0 conditions, and to 3 interventions - of which Telmisartan & Hydrochlorothiazide is the first listed.
NCT00274638 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00274638 about?
NCT00274638 is a clinical study titled "PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)". To demonstrate that Telmisartan combined with Hydrochlorothiazide (MICARDIS® HCT) is superior to Losartan with Hydrochlorothiazide (Hyzaar®) in lowering blood pressure in mild-moderate hypertensives.
What is the current status of trial NCT00274638?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 805 participants. The study started on 2002-07.
What interventions are being tested in trial NCT00274638?
The interventions under investigation include: Telmisartan & Hydrochlorothiazide (DRUG), Losartan & Hydrochlorothiazide (DRUG), ABPM (PROCEDURE).
Who is sponsoring clinical trial NCT00274638?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00274638's enrollment target sits among peer trials
805 97th of 2000 higher than 1,904 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
- NCT04423211 · 804 participants · Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- NCT06522022 · 804 participants · NA
PTSD Screening in Pregnant Black Women
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia